As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict what the next big ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
December 22, 2014 — AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have ...
December 19, 2014 — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 18, 2014 — Topera, Inc. announced that its RhythmView 3-D Mapping System received the Most Innovative New ...
December 8, 2014 — Researchers at the Minneapolis Heart Institute Foundation have found that when care teams started ...
December 4, 2014 — Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...
November 24, 2014 — Obesity is a known risk factor for atrial fibrillation (AFib), the most common heart rhythm disorder ...
Nov. 5, 2014 — Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
October 30, 2014 — New physician experience for the Convergent Procedure in the treatment of persistent atrial ...
October 28, 2014 — St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval of its ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
October 17, 2014 – The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and ...
October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.
As of ...
October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage ...